✦ LIBER ✦

Failure to Enhance the in Vivo Killing of Human Ovarian Carcinoma by Sequential Treatment with Dequalinium Chloride and Tumor Necrosis Factor

✍ Scribed by Alberto Manetta; Dennis Emma; Gisela Gamboa; Shu Liao; Michael Berman; Philip Disaia

Book ID: 115615877
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 329 KB
Volume: 50
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1993.1161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced in vivo killing of ovarian carc

Enhanced in vivo killing of ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor

✍ A. Manetta; D. Emma; G. Gamboa; S. Liao 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Overcoming tumor necrosis factor-α resis

Overcoming tumor necrosis factor-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-α. Role of tumor necrosis factor-α mRNA down-regulation in tumor cell sensitization

✍ Youichi Mizutani; Osamu Yoshida 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 871 KB

Involvement of the mitochondrion respira

Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-α and cis-diamminedichloroplatinum

✍ Ruchan Uslu; Benjamin Bonavida 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## BACKGROUND. Previous studies have demonstrated that treatment of human tumor cell lines with a combination of cis-diamminedichloroplatinum (CDDP) and tumor necrosis factor-a (TNF-a) results in additivelsynergistic cytotoxic effects and reverses tumor cell resistance to TNF drugs. Free radical i